A Retrospective Chart Review on the Use of Biologics in Monotherapy for the Treatment of Patients With Rheumatoid Arthritis
NCT ID: NCT01640548
Last Updated: 2016-11-02
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
320 participants
OBSERVATIONAL
2012-09-30
2013-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cohort
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of rheumatoid arthritis by a Rheumatologist
* Patient being prescribed with a biologic in monotherapy
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hoffmann-La Roche
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trials
Role: STUDY_DIRECTOR
Hoffmann-La Roche
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abergavenny, , United Kingdom
Basildon, , United Kingdom
Basingstoke, , United Kingdom
Belfast, , United Kingdom
Blackburn, , United Kingdom
Bournemouth, , United Kingdom
Cambridge, , United Kingdom
Cannock, , United Kingdom
Dewsbury, , United Kingdom
Dudley, , United Kingdom
Durham, , United Kingdom
Eastbourne, , United Kingdom
Edinburgh, , United Kingdom
Glasgow, , United Kingdom
Greenock, , United Kingdom
Harlow, , United Kingdom
Inverness, , United Kingdom
Kirkcaldy, , United Kingdom
London, , United Kingdom
Portsmouth, , United Kingdom
Sheffield, , United Kingdom
Truro, , United Kingdom
Warrington, , United Kingdom
Westbury-on-Trym, Bristol, , United Kingdom
Wigan, , United Kingdom
Wolverhampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ML28372
Identifier Type: -
Identifier Source: org_study_id